Select for export Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/09540261.2024.2357668 PubMed 39980217 Copy citation Copy BibTeX Unknown journal 2024-05-22 Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB. Europe PMC Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/add.16518 PubMed 38771189 Copy citation Copy BibTeX Addiction 2024-05-20 Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell, Wayne Hall, Julia Lappin OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyToxicity Other More
Select for export A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient Abstract available at the source but not redistributed here. Read at source. Details DOI 10.9758/cpn.24.1180 PubMed 39420616 Copy citation Copy BibTeX Clinical Psychopharmacology and Neuroscience 2024-05-20 S Morris OpenAlex Published psilocybin DepressionAnxietyPersonality Change Review Article More
Select for export Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s13063-024-08174-x PubMed 38773523 Copy citation Copy BibTeX Unknown journal 2024-05-19 Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.05.16.594614 Copy citation Copy BibTeX bioRxiv 2024-05-16 Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionMechanism of ActionClinical Trial Clinical Trial More
Select for export Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pcn5.196 Copy citation Copy BibTeX Psychiatry and Clinical Neurosciences Reports 2024-05-15 Shunichiro Ikeda, Toshihiko Kinoshita OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jaac.2024.03.021 PubMed 38734406 Copy citation Copy BibTeX Unknown journal 2024-05-08 Jeffrey JK, Weintraub MJ, Grob CS. Europe PMC Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-05-07 Nova Mentis Life Science Corp ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Review Article More
Select for export Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-05-06 University of Calgary ClinicalTrials.gov CLINICAL TRIAL psilocybin AddictionBrain ImagingMechanism of Action Clinical Trial More
Select for export What is needed for the roll-out of psychedelic treatments? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/yco.0000000000000946 PubMed 38726805 Copy citation Copy BibTeX Current Opinion in Psychiatry 2024-05-06 Stephen N. Xenakis, Scott Shannon OpenAlex Published psilocybin PTSDChronic PainPharmacology Clinical Trial More
Select for export EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmj.q1025 PubMed 38704154 Copy citation Copy BibTeX BMJ 2024-05-03 British Medical Journal Publishing Group OpenAlex Published psilocybin DepressionClinical TrialMeta-Analysis Meta-Analysis More
Select for export Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31986/issn.2689-0690_rdw.stratford_research_day.149_2024 Copy citation Copy BibTeX Unknown journal 2024-05-01 Hanna Brancaccio OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/sw/swae019 PubMed 38697188 Copy citation Copy BibTeX Social Work 2024-05-01 Claire Parker, Bethany Wood OpenAlex Published psilocybin DepressionAddictionMechanism of Action Clinical Trial More
Select for export From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine Abstract available at the source but not redistributed here. Read at source. Details DOI 10.59324/ejahss.2024.1(3).10 Copy citation Copy BibTeX European Journal of Arts Humanities and Social Sciences 2024-04-30 Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmj-2023-078084 PubMed 38692686 Copy citation Copy BibTeX Unknown journal 2024-04-30 Metaxa AM, Clarke M. Europe PMC Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-024-06598-6 PubMed 38683460 Copy citation Copy BibTeX Unknown journal 2024-04-28 Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL. Europe PMC Published psilocybin Randomized Controlled TrialSystematic ReviewReview Article Randomized Controlled Trial More
Select for export Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-024-02575-9 PubMed 38678087 Copy citation Copy BibTeX Molecular Psychiatry 2024-04-26 Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus OpenAlex Published psilocybin DepressionEating DisordersPharmacology Clinical Trial More
Select for export MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.05.5.1 Copy citation Copy BibTeX Psychiatric News 2024-04-22 Terri D’Arrigo OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.04.19.590212 Copy citation Copy BibTeX bioRxiv 2024-04-21 Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E bioRxiv PREPRINT (not peer reviewed) psilocybin Receptor PharmacologyClinical TrialAnimal Study Clinical Trial More
Select for export The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-04-18 Section for Affective Disorders; Northern Stockholm Psychiatry ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
